Muscarinic Receptors in Equine Airways

The distribution of muscarinic receptors in equine airways was investigated using autoradiography. Frozen sections of tissue from six different levels in the bronchial tree, from the trachea to the distal bronchioles, were incubated in vitro with 1.5 nmol/L of the muscarinic receptor antagonist 1-[N-methyl-³H]scopolamine methyl chloride (³H-NMS). In addition, the subtype pattern of muscarinic receptors was investigated in equine tracheal smooth muscle using radioligand binding with methoctramine, tripinamide, 4-DAMP-methiodide and pirenzipine as competitors against the binding of 1.3 nmol/L ³H-NMS. The autoradiograms showed specific labelling indicating a high density of muscarinic receptors in smooth-muscle tissue in all levels of the airway tree investigated. Besides muscle tissue, subepithelial glands were the only structures specifically labelled. The dominating subtypes in tracheal smooth muscle investigated with radioligand binding studies were found to be M₂ and M₄, as both methoctramine (pK _d = 8.5) and tripinamide (pK _d = 8.6 and 6.7 for two different sites) showed high affinity. The density of the M₃-muscarinic receptor subtype was low, but this subtype could be detected with statistical significance when methoctramine was used as the competitor against ³H-NMS binding.     

Electromechanical effects of acetylcholine on the atrial tissues of the cultured tilapia (Oreochromis nilotica × O. aureus)

The effects of acetylcholine (ACh) on the action potential and twitch force of atrial tissues isolated from 15 tilapia (Oreochromis nilotica × O. aureus) were studied by means of conventional microelectrode techniques. In isolated whole atrium or sinoatrial tissue, scattered pacemaker-like cells with spontaneous diastolic depolarization were found mainly near the sinoatrial junction but also occasionally throughout the atrial wall. However, most of the atrial cells recorded were myocardial fibers as judged by a stable diastolic potential and a markedly reduced action potential duration (APD) in response to low concentrations of ACh (0.1–1 M). The shortening in APD in atrial myocardial fibers was correlated with a significant fall in twitch force in the atrial preparations. ACh at high concentrations (10–300 M) decreased moderately the APD and the slope of diastolic depolarization of the pacemakers and prolonged the spontaneous cycle length but did not induce hyperpolarization. The negative chronotropic action of ACh was competitively inhibited by atropine, a muscarinic antagonist. The means (± SEM) negative logarithm of the dissociation constant (pK_b or pA₂ value) for atropine against the ACh action on muscarinic receptors were 9.10 (± 0.13) (n = 6), similar to those values obtained in mammalian atria. The present findings indicate that while the negative inotropic effects of ACh in tilapia atria are comparable to those observed in mammalian hearts, unique electrophysiological responses to ACh exist in different types of tilapia atrial cells.     

Preparation of m1AChR-G11 fusion protein and m4AChR-G16 fusion protein and effects of various ligands on them

AIM:To prepare m₁AChR-G₁₁ and m₄AChR-G₁₆ fusion protein in Baculovirus-Sf9 cell system and detect the effects of various muscarinic ligands on the interaction between m₁AChR and G₁₁ and m₄AChR and G₁₆, and screen different kinds of ligands specific for m₁ and m₄. METHODS:To prepare fused DNA of m₁AChR-G₁₁and m₄AChR-G₁₆ in two PCR, then expressed in Sf9 cells and detect the pharmacological function of m₁AChR-G₁₁ fusion protein and m₄AChR-G₁₆ fusion protein by QNB and GTPγS binding experiments; To expore the way of the activation of m₁AChR-G₁₁ and m₄AChR-G₁₆ fusion protein by various ligands includingcetylcholine (ACh), Pilocarpine (Pilo), 4-hydroxy-2-butynyl-1-trimethylammonium-m-chloro-carbanilatechloride (McN-A-343), tetrandrine, pirenzepine (PZ), alcuronium, atropine, R-(+)-hyoscyamine and gallamine by displacement by GDP on GTPγS binding experiments. RESULTS:The expression levels of m₁AChR-G₁₁ and m₄AChR-G₁₆ fusion protein were (45.39±2.62) nmol·g^-1 protein, (47.04±1.58) nmol·g^-1 protein. The affinity of GDP to G₁₁ and G₁₆ partner changed in the presence of different muscarinic ligands. CONCLUSION: The m₁AChR-G₁₁ and m₄AChR-G16 showed the pharmacological specificity to m₁ and m₄ receptor and the efficient signaling of the two partners. Ligands of m₁AChR and m₄AchR mediated different signal transduction by changing the affinity of G₁₁/G₁₆ and GDP. So m₁AChR-G₁₁ fusion protein and m₄AChR-G₁₆ fusion protein can be taken as a tool to screen ligands specific for m₁AChR and m₄AChR.     

Presence of Muscarinic Acetylcholine Receptors in the Cattle Tick Boophilus microplus and in Epithelial Tissue Culture Cells of Chironomus tentans

A muscarinic acetylcholine receptor (mAChR) has been demonstrated and partially characterized in larvae of the cattle tick Boophilus microplus. Its properties are compared with mAChR from an epithelial cell line from the dipteran insect Chironomus tentans. Competition studies with cholinergic ligands of different specificity revealed the muscarinic nature of the cholinergic receptors investigated in both species. In homogenates from tick larvae, specific binding sites for [³H]quinuclidinyl benzilate (QNB) with high affinity (1·2±(0·13) nM ; B_max 22·5 pmol mg protein⁻¹) were detected that do not bind nicotinic compounds specifically. The estimated IC₅₀ values for nicotine, imidacloprid and α-bungarotoxin were all in the mM range. Additionally, with tick larvae, high-affinity nicotinic binding sites were detected with [³H]nicotine which could be displaced by high concentrations of imidacloprid or QNB. The estimated IC₅₀ values for nicotine, α-bungarotoxin, imidacloprid and QNB were 43(±8) nM , 0·8(±0·2) μM , 2·8(±0·6) μM and 78(±1·9) μM , respectively. With homogenates of the non-neuronal insect cell line from C. tentans, only high-affinity binding sites for [³H]QNB were found. Muscarinic antagonists selectively displaced [³H]quinuclidinyl benzilate (QNB) binding to tick larvae homogenates. The mAChR of B. microplus preferred pirenzepine (IC₅₀ 2·13(±1·02) μM ) among different subtype-specific mAChR antagonists (4-DAMP had IC₅₀ 49·9(±9·13) μM and methoctramine had IC₅₀ 121(±14·2) μM ) indicating a type of binding site similar to the vertebrate M1 mAChR subtype. The tick muscarinic receptor seems to be a G-protein-coupled receptor, as concluded from the 4·8-fold reduction in receptor affinity for binding of the muscarinic agonist oxotremorine M upon treatment with the non-hydrolysable GTP-analogue γ-S-GTP. Binding data for the agonists oxotremorine M (IC₅₀ 71·3(±19·6) μM ) and carbachol (IC₅₀ 253(±87·1) μM ) parallel the biological efficacy of these compounds, in that, while oxotremorine M showed some activity against ticks, carbachol was ineffective.     

Muscarinic receptor subtypes in equine tracheal smooth muscle

Selective muscarinic receptor antagonists were used to identify muscarinic receptor subtypes in equine trachealis strips. The M₁ receptor antagonist pirenzepine (10^–7 mol/L to 3 × 10^–5 mol/L) and the M₃ receptor antagonist 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, 10^–9 mol/L to 3 × 10^–7 mol/L³) dose dependently inhibited the contractile responses to electrical field stimulation (EFS) and exogenous acetylcholine (ACh). Schild plots yielded a pA₂ value for pirenzepine vs ACh of 6.75 ± 0.09, which is consistent with the affinity for M₂ or M₃ receptors, and a pA₂ value for 4-DAMP vs ACh of 8.47 ± 0.09, which is in agreement with the affinity for M₃ receptors. The M₂ receptor antagonist gallamine (10^–5 mol/L and 10^–4 mol/L) did not affect the response of trachealis to exogenous ACh and low-frequency EFS (0.1–2 Hz) but decreased the responses to high-frequency EFS (4–16 Hz). These results suggest that the muscarinic receptors mediating contractions induced by ACh in equine tracheal smooth muscle are of the M₃ subtype. The lack of an increase in the response to EFS following gallamine suggests that functional prejunctional inhibitory M₂ receptors are not present on the cholinergic nerves innervating equine tracheal smooth muscle.     

Mediation of serotonin-induced branchial vasoconstriction by a cholinergic and muscarinic responsein vivo in European eelAnguilla anguilla

The intravenous administration of serotonin (5-hydroxytryptamine: 5-HT) induced a significant branchial vasoconstrictionin vivo in European eel. This effect is blocked either by methysergide or atropine treatment suggesting a mediation of the serotonin-induced vasoconstriction by both methysergide-sensitive serotonergic receptors and by cholinergic muscarinic receptors of the branchial vasculature. The intravenous administration of 5-HT caused an increase (250%) in ventilatory water flow (V_W) together with a rise (250%) in partial pressure of oxygen in arterial blood (PaO₂). Under imposed steady ventilatory water flow in curarized eels, serotonin induced a significant increase in PaO₂ which i) appeared at the time of branchial vasoconstriction, ii) was blocked by methysergide treatment, and iii) was not related to an elevation of plasma catecholamine levels. These results suggest that 5-HT causes a constriction of branchial vasculature in a site where serotonergic and cholinergic receptors are both present. The localization of serotonin-induced branchial vasoconstriction is discussed.     

Efficacy of tropicamide,homatropine, cyclopentolate,atropine and hyoscine as mydriatics in Angora goats

Abstract

AIM: To document the efficacy of five commercially available mydriatics for their potential for diagnostic and therapeutic use in Angora goats.

METHODS: Over 8 weeks, the mydriatic effects of 1% tropicamide, 2% homatropine, 1% cyclopentolate, 1% atropine and 0.25% hyoscine were evaluated. Given as block treatments, drugs were applied randomly to one eye of 10 Angora goats, and the contralateral eye served as a control. Vertical and horizontal pupil diameters were measured to document onset ofeffect, time to reach a difference of 5 mm in the vertical/horizontal pupil diameter between eyes, time to maximum pupillary dilation, and duration of mydriatic action.

RESULTS: Onset of mydriasis for all drugs occurred within 15 minutes. Time to reach a difference of 5 mm in the vertical pupil diameter between eyes was shortest for 1% tropicamide and 0.25% hyoscine (0.5 h), then 2% homatropine and 1% atropine (0.75 h), and longest for 1% cyclopentolate (1.5 h). The maximum vertical pupillary dilation occurred earliest with 1% tropicamide and 1% atropine (2 h), followed by 0.25% hyoscine (3 h), 2% homatropine (4 h), and latest with 1% cyclopentolate (8 h). The duration of vertical dilation of the pupil was shortest with 1% tropicamide (6 h), then 2% homatropine (12 h), 1% cyclopentolate (12 h), 1% atropine (24 h), and longest for 0.25% hyoscine (96 h).

The time to reach maximum horizontal dilation of the pupil in treated eyes was shortest with 1% cyclopentolate (1 h), followed by 1% tropicamide (1.5 h), 0.25% hyoscine (3 h), 2% homatropine (3.5 h), and 1% atropine (4 h). The duration of horizontal pupil dilation was shortest with 1% tropicamide (4.5 h), and longest with 0.25% hyoscine (48 h).

CONCLUSION: All five mydriatics induced clinical dilation. Tropicamide (1%) had the shortest duration of effect, but gave incomplete dilation. Good dilation was achieved with 1% cyclopentolate and 2% homatropine, but took too long to reach maximum dilation for routine mydriasis. The largest vertical dilation of the pupil was achieved with 1% atropine and 0.25% hyoscine, but pupils remained dilated for more than 24 h.

CLINICAL RELEVANCE: For routine mydriasis in goats, it is recommended that 1% tropicamide be used, though there may be incomplete dilation. For a longer duration of mydriasis, such as in the treatment of anterior uveitis, 1% atropine or 0.25% hyoscine would be the drugs of choice.     

Segment-dependent Expression of Muscarinic Acetylcholine Receptors and G-protein Coupling in the Equine Respiratory Tract

Muscarinic receptors are considered to be of comparable clinical importance in chronic obstructive pulmonary disease (COPD) in equines and in humans. At present, data are scarce on the expression and distribution of probable subtypes of these receptors and their signalling pathways in airway segments, including lung parenchyma and bronchial and tracheal epithelium with the underlying smooth muscle in horses. Specific [N-methyl-³H]scopolamine chloride ([³H]NMS) binding to all three tissues was saturable and of high affinity, with K _D values ranging between 1.6±0.7 and 1.9±0.3 nmol/L. [³H]NMS binding identified a higher density of total muscarinic receptors (fmol/mg protein) in the trachea (720±59 nmol/L) than in bronchi (438±48 nmol/L) or lung (22 ± 3 nmol/L). Competitive binding studies using [³H]NMS and the unlabelled subtype-selective antagonists pirenzepine and telenzepine (M₁), methoctramine and himbacine (M₂), 4-diphenylacetoxy-N-methylpiperidine (4-DAMP) (M₃), tropicamide (M₄) and mamba toxin (MT-3) (M₄) indicated the presence of at least three muscarinic receptor subtypes in peripheral lung tissue (50:40:24–28%: M₂>M₃>M₁), whereas in bronchus and trachea M₂ subtypes (87–90%) predominated over M₃ (14–22%), and M₁ subtypes were lacking. No differences were found between tissues in high-affinity binding sites for carbachol in the absence (31–36%) or presence of guanosine 5^′-triphosphate (GTP) (∼100%). Western blotting for G-protein α-subunits showed a much more robust expression of G_αi1/2 in the trachea (with highest receptor density) than in the lung or bronchi, whereas G_αs-protein was dominantly expressed in bronchus. Concomitantly, carbachol inhibited isoproterenol- and GTP-stimulated adenylyl cyclase activity with increasing muscarinic receptor expression (trachea > bronchi > lung). We conclude that the expression and signalling pathways of muscarinic receptors in the equine respiratory tract are segment-dependent. These receptors might contribute to the pathogenesis of COPD in the horse and could provide potential drug targets for the therapeutic use of anticholinergics in this species.     

The influence of ageing on muscarinic receptors, β-adrenoceptors and adenylate cyclase activity in the bovine lung

Muscarinic and -adrenoceptors were identified in airway epithelium, smooth muscle and lung parenchyma from Holstein-Friesian calves and cows and were characterized with [³H]quinuclidinyl benzilate and [³H]dihydroalprenolol, respectively. The muscarinic receptor density in the smooth muscle of cows (B _max=4803±245 fmol/mg protein) was 33% greater (p<0.01) than in calves. Low receptor numbers were detected in the epithelium and parenchyma. In both calves and cows, the density of epithelial -adrenoceptors was twice as high as in smooth muscle and parenchyma. The quantity of -adrenoceptors in the tracheal epithelium (B _max=994±83 fmol/mg protein) and smooth muscle (B _max=492±41 fmol/mg protein) in cows was respectively 37% (p<0.001) and 35% (p<0.01) lower than in calves. Adenylate cyclase (AC) assays indicated that the basal and the (–)-isopropylnoradrenaline- (ISO-) stimulated cAMP production were not significantly different between the calves and cows. After stimulation with NaF, significantly higher cAMP production was found in all tissues from cows. Significant correlations were found between absolute AC responses to NaF and -adrenoceptor density in epithelium (r=–0.75,p<0.001) and smooth muscle (r=–0.63,p<0.01). It seems that, in older animals, the production of cAMP is independent of the number of receptors, indicating the presence of fully active compensatory mechanisms.Abbreviations AC adenylate cyclase - cAMP intra-cellular adenosine monophosphate - G-protein GTP binding protein - GTP guanosine 5-triphosphate - ISO isopropylnoradrenaline - M muscarine - QNB quinuclidinyl benzilate